When it comes to outsourcing in 2025, it is no longer about who can do it the cheapest—it is about developing partnerships ...

One of the primary drivers behind the adoption of biologics contract manufacturing is the potential for significant cost savings. By outsourcing production to a CDMO, pharmaceutical companies can ...

Beginning in more systematic areas such as clinical development and manufacturing, outsourcing has witnessed strong growth over the past years, particularly in contract manufacturing (CMOs ...

June in Berlin, addresses the growing pharmaceutical outsourcing requirements in contract manufacturing, bulk, fill finish, drug delivery and API sourcing. The Global Pharmaceutical Contract ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

As outsourcing gains wider acceptance as a practical and advantageous business model in this sector, the global market for biologics contract manufacturing is anticipated to experience significant ...

As specialized clinics, labs, and research centers augment production lines, the dental implants and prosthetics contract ...

Arterex said the deal expands its capabilities in medical device development, finished device assembly and packaging to ...